Drug intelligence / Profile preview

amino acid (15) peritoneal dialysis solution

Development stage
Unknown
Lead developer
Chengdu Qingshan Likang Pharmaceutical
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

Amino acid (15) peritoneal dialysis solution is a specialized dialysis fluid containing a mixture of 15 essential and non-essential amino acids, developed by Chengdu Qingshan Likang Pharmaceutical. It is designed for use in patients with End-Stage Renal Disease (ESRD) undergoing Continuous Ambulatory Peritoneal Dialysis (CAPD), specifically those who are suffering from protein-energy malnutrition. Unlike traditional glucose-based solutions, this formulation uses amino acids as the osmotic agent to facilitate ultrafiltration and the removal of metabolic waste products. Simultaneously, it provides a nutritional source of nitrogen as the amino acids are absorbed across the peritoneal membrane into the systemic circulation, helping to improve the patient's nutritional status and mitigate the protein loss often associated with long-term peritoneal dialysis.

Brand names
Nutrineal
Other names
amino acid peritoneal dialysis solutionamino acid-based peritoneal dialysis solution
02

Targets

SERPINA1 (Alpha-1-antitrypsin)

Beyond the preview

Go deeper on amino acid (15) peritoneal dialysis solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amino acid (15) peritoneal dialysis solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call